Director/PDMR Shareholding
Physiomics plc announced that Director Ian Bagnall purchased 1,111,111 new ordinary shares at 0.45p per share, costing a total of £5,000. This acquisition increases his total holding to 16,111,111 ordinary shares, representing approximately 3.55% of the company's issued share capital. The transaction occurred on the London Stock Exchange on July 10, 2026.
Select text to share a quote on X · sign in to keep highlights & notes in your PYC notes
Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions, announces that Ian Bagnall, Director of the Company, has acquired, via market purchases, 1,111,111 new ordinary shares of 0.4p in the Company ("Ordinary Shares") at a price of 0.45p per Ordinary Share.
Accordingly, Mr Bagnall's total holding in the Company will be 16,111,111 Ordinary Shares, representing approximately 3.55% of the Company's issued share capital.
For more information about Physiomics and its services, please visit www.physiomics.co.uk.
| a) | Name | Ian Bagnall | ||||
| 2. | Reason for the Notification | |||||
| a) | Position/status | Executive Director | ||||
| b) | Initial notification/amendment | Initial notification | ||||
| a) | Name | Physiomics plc | ||||
| b) | LEI | 213800A71DSZ6ABMTQ91 | ||||
| a) | Description of the Financial instrument, type of instrument | Purchase of Ordinary Shares | ||||
| Identification code | GB00BDR6W943 | |||||
| b) | Nature of the Transaction | Purchase of new Ordinary Shares | ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information Aggregated volume Price | N/A (Single transaction) | ||||
| e) | Date of the transaction | 10 July 2026 | ||||
| f) | Place of the transaction | London Stock Exchange |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.